|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 USD | -5.02% |
|
-7.17% | -80.23% |
| Apr. 01 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
| Apr. 01 | Top Premarket Decliners | MT |
Nov 29 (Reuters) - Vivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device treatment for severe obstructive sleep apnea (OSA). (Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
| 1st Jan change | Capi. | |
|---|---|---|
| -80.23% | 7.72M | |
| +73.15% | 12.36B | |
| -20.53% | 7.83B | |
| +15.86% | 7.21B | |
| +4.77% | 5.97B | |
| +11.77% | 5.14B | |
| +29.65% | 4.43B | |
| -18.81% | 3.9B | |
| -41.91% | 2.2B | |
| +1.24% | 2.02B |
VIVOS THERAPEUTICS, INC. 
